Precision PromiseSM Adaptive Clinical Trial Leadership

Home Research Precision PromiseSM Precision PromiseSM Adaptive Clinical Trial Leadership

PanCAN brings together key stakeholders – investigators, clinicians, industry and pancreatic cancer thought-leaders – to make this historic initiative possible with the goal to bring new treatment options to patients.

Precision Promise Steering Committee

Diane Simeone, MD, chair, Perlmutter Cancer Center/NYU Langone Health
Sudheer Doss, PhD, Chief Data Officer, PanCAN
Andrew Hendifar, MD, Cedars-Sinai Medical Center
Manuel Hidalgo, MD, PhD, Weill Cornell Medicine
Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center
Victoria Manax, MD, Chief Medical Officer, PanCAN
Lynn Matrisian, PhD, MBA, Chief Science Officer, PanCAN
Vincent Picozzi, MD, Virginia Mason Medical Center

Precision Promise Sub-Committees

Design Committee

Biomarker Committee

Supportive Care Committee

Arms Selection Committee

Operations Committee

Clinical Trial Consortium Committee

Thank you to our current Scientific & Medical Affairs Industry Members

SMA Industry Members

PanCAN is grateful for the early support from our Founding Precision Promise Members

logo-celgene-committed

astrazeneca-logo
logo janssen

logo-bristol-myers-squibb
logo-Halozyme-150x

 
PRECISION PROMISESM is a service mark of Pancreatic Cancer Action Network, Inc.

Wage Hope With Us

Join us to make a difference for pancreatic cancer patients.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2020 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.